Multi-source feedback (MSF) for specialty trainees

MSF has been built into the Learning Environment for Pathology Trainees (LEPT) system. This is the College’s web-based system for workplace-based assessment which also includes a full e-Portfolio function.

MSF for ST1 specialty trainees (Stage A)

The Royal College of Pathologists has developed an MSF assessment tool specifically for StRs who are completing the requirements of the ST1/Stage A of a General Medical Council (GMC) approved training programme in chemical pathology, chemical pathology (metabolic medicine) and histopathology. 

Medical microbiology and virology trainees should access their MSF via the JRCPTB ePortfolio.

MSF Assessments for Year 2 and Year 4 Trainees

MSF for ST3/5 and ST5/7 specialty trainees (Stages B-C/D)

The Royal College of Pathologists has developed a universal pathology focussed multi-source feedback (MSF) tool for StRs who are completing the requirements of Stage B - D of a General Medical Council (GMC) approved training programme in chemical pathology, chemical pathology (metabolic medicine), histopathology diagnostic neuropathology, forensic histopahtology and paediatric and perinatal pathology.  The MSF generates part of the necessary evidence for appraisal and the annual review of competence progression (ARCP).

It is a requirement for pathology trainees to undertake three MSF assessments during training – at ST1/3, ST3/5 and ST5/7 prior to the award of a Certificate of Completion of Training (CCT). This is in addition to workplace-based assessments.

Medical microbiology and virology trainees should access their MSF on the JRCPTB ePortfolio unless they are completing training on the original 2010 medical microbiology or medical virology curricula. 

Please note that unlike ST1 trainees, ST3/5 and ST5/7 trainees will not receive notification from the College regarding the initiating of MSF assessments. ST3/5 and ST5/7 trainees must commence the process themselves via the LEPT system in a timely manner to coincide with any forthcoming ARCPs.